Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Musculoskeletal | Family Medicine

Clinical Trials: Osteosarcoma


A listing of clinical trials currently looking for volunteers to enroll in Osteosarcoma studies. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : University of Alabama

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

California

Los Angeles : UCLA/Mattel's Children's Hospital

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Los Angeles : Children's Hospital Los Angeles

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Palo Alto : Stanford University

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

San Francisco : UCSF

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Santa Monica : Sarcoma Oncology Center

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

View More »

Stanford : Stanford University School of Medicine

Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma

Florida

Gainesville : University of Florida

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Miami : University of Miami

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Tampa : H. Lee Moffitt Cancer Center

Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma

Iowa

Iowa City : University of Iowa Hospitals and Clinics

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Maryland

Baltimore : Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Bethesda : National Cancer Institute

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Massachusetts

Boston : Dana-Farber Cancer Institute

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Michigan

Ann Arbor : University of Michigan

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

New York

The Bronx : The Children's Hospital at Montefiore

Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma

Ohio

Cincinnati : Cincinnati Children's Hospital Medical Center

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Oregon

Portland : OHSU Knight Cancer Institute

Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma

Pennsylvania

Philadelphia : Pennsylvania Hematology Oncology Associates

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Tennessee

Memphis : St. Jude Children's Research Hospital

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Washington

Seattle : Seattle Cancer Care Alliance/University of Washington Medical Center

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Austria

Wien : AKH Wien Universitätsklinik für Innere Medizin I Klinische Abteilung für Onkologie

Surveillance Study of Patients With Newly Diagnosed Osteosarcoma

China

Beijing : The Military General Hospital of Beijing PLA

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Jinan : General Hospital of Jinan Military Command

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Nanjing : Nanjing General Hospital of Nanjing Military Command

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Xi'an : Xijing Hospital

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Israel

Ramat Gan : Sheba MC

Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System

Ramat Gan : Sheba MC

Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma